113 related articles for article (PubMed ID: 16051276)
1. Gastrointestinal hormone receptors in primary human colorectal carcinomas.
Chao C; Tallman ML; Ives KL; Townsend CM; Hellmich MR
J Surg Res; 2005 Dec; 129(2):313-21. PubMed ID: 16051276
[TBL] [Abstract][Full Text] [Related]
2. The CCK-2/gastrin splice variant receptor retaining intron 4 transactivates the COX-2 promoter in vitro.
Huang H; Ansorge N; Schrader H; Banasch M; Yu HG; Schmidt WE; Höcker M; Schmitz F
Regul Pept; 2007 Dec; 144(1-3):34-42. PubMed ID: 17936921
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors.
Williams CJ; Mitsiades N; Sozopoulos E; Hsi A; Wolk A; Nifli AP; Tseleni-Balafouta S; Mantzoros CS
Endocr Relat Cancer; 2008 Mar; 15(1):289-99. PubMed ID: 18310295
[TBL] [Abstract][Full Text] [Related]
4. Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon.
Matusiak D; Glover S; Nathaniel R; Matkowskyj K; Yang J; Benya RV
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G718-28. PubMed ID: 15528253
[TBL] [Abstract][Full Text] [Related]
5. Receptor subtype expression and responsiveness to bombesin in cultured human bronchial epithelial cells.
Frankel A; Tsao MS; Viallet J
Cancer Res; 1994 Apr; 54(7):1613-6. PubMed ID: 8137267
[TBL] [Abstract][Full Text] [Related]
6. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14).
Reubi JC; Wenger S; Schmuckli-Maurer J; Schaer JC; Gugger M
Clin Cancer Res; 2002 Apr; 8(4):1139-46. PubMed ID: 11948125
[TBL] [Abstract][Full Text] [Related]
7. Bombesin family receptor and ligand gene expression in human colorectal cancer and normal mucosa.
Chave HS; Gough AC; Palmer K; Preston SR; Primrose JN
Br J Cancer; 2000 Jan; 82(1):124-30. PubMed ID: 10638978
[TBL] [Abstract][Full Text] [Related]
8. Gastrin suppresses growth of CCK2 receptor expressing colon cancer cells by inducing apoptosis in vitro and in vivo.
Müerköster S; Isberner A; Arlt A; Witt M; Reimann B; Blaszczuk E; Werbing V; Fölsch UR; Schmitz F; Schäfer H
Gastroenterology; 2005 Sep; 129(3):952-68. PubMed ID: 16143134
[TBL] [Abstract][Full Text] [Related]
9. Expression of gastrin-releasing peptide receptors in endometrial cancer.
Levine L; Licci JA; Townsend CM; Hellmich MR
J Am Coll Surg; 2003 Jun; 196(6):898-904. PubMed ID: 12788426
[TBL] [Abstract][Full Text] [Related]
10. Neurotensin receptors in adeno- and squamous cell carcinoma.
Haase C; Bergmann R; Oswald J; Zips D; Pietzsch J
Anticancer Res; 2006; 26(5A):3527-33. PubMed ID: 17094477
[TBL] [Abstract][Full Text] [Related]
11. Expression and localization of homeodomain proteins DLX4, HB9 and HB24 in malignant and benign human colorectal tissues.
Hollington P; Neufing P; Kalionis B; Waring P; Bentel J; Wattchow D; Tilley WD
Anticancer Res; 2004; 24(2B):955-62. PubMed ID: 15161049
[TBL] [Abstract][Full Text] [Related]
12. Expression of the gastrin-releasing peptide receptor confers a growth response to bombesin in immortalized human bronchial epithelial cells.
al Moustafa AE; Tsao MS; Battey JF; Viallet J
Cancer Res; 1995 May; 55(9):1853-5. PubMed ID: 7728752
[TBL] [Abstract][Full Text] [Related]
13. Effect of leuprolide and cetrorelix on cell growth, apoptosis, and GnRH receptor expression in primary cell cultures from human prostate carcinoma.
Castellón E; Clementi M; Hitschfeld C; Sánchez C; Benítez D; Sáenz L; Contreras H; Huidobro C
Cancer Invest; 2006; 24(3):261-8. PubMed ID: 16809153
[TBL] [Abstract][Full Text] [Related]
14. The apoptosis-inducing effect of gastrin on colorectal cancer cells relates to an increased IEX-1 expression mediating NF-kappa B inhibition.
Sebens Müerköster S; Rausch AV; Isberner A; Minkenberg J; Blaszczuk E; Witt M; Fölsch UR; Schmitz F; Schäfer H; Arlt A
Oncogene; 2008 Feb; 27(8):1122-34. PubMed ID: 17704804
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology and intracellular signaling mechanisms of the native human orphan receptor BRS-3 in lung cancer cells.
Ryan RR; Weber HC; Mantey SA; Hou W; Hilburger ME; Pradhan TK; Coy DH; Jensen RT
J Pharmacol Exp Ther; 1998 Oct; 287(1):366-80. PubMed ID: 9765358
[TBL] [Abstract][Full Text] [Related]
16. Gastrin increases its own synthesis in gastrointestinal cancer cells via the CCK2 receptor.
Kovac S; Xiao L; Shulkes A; Patel O; Baldwin GS
FEBS Lett; 2010 Nov; 584(21):4413-8. PubMed ID: 20932834
[TBL] [Abstract][Full Text] [Related]
17. A human three-dimensional cell line model allows the study of dynamic and reversible epithelial-mesenchymal and mesenchymal-epithelial transition that underpins colorectal carcinogenesis.
Vincan E; Brabletz T; Faux MC; Ramsay RG
Cells Tissues Organs; 2007; 185(1-3):20-8. PubMed ID: 17587804
[TBL] [Abstract][Full Text] [Related]
18. Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
Lubbe WJ; Zhou ZY; Fu W; Zuzga D; Schulz S; Fridman R; Muschel RJ; Waldman SA; Pitari GM
Clin Cancer Res; 2006 Mar; 12(6):1876-82. PubMed ID: 16551873
[TBL] [Abstract][Full Text] [Related]
19. Increased frequency of gastrin-releasing peptide receptor gene mutations during colon-adenocarcinoma progression.
Glover SC; Tretiakova MS; Carroll RE; Benya RV
Mol Carcinog; 2003 May; 37(1):5-15. PubMed ID: 12720295
[TBL] [Abstract][Full Text] [Related]
20. Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.
Bakkum-Gamez JN; Aletti G; Lewis KA; Keeney GL; Thomas BM; Navarro-Teulon I; Cliby WA
Gynecol Oncol; 2008 Jan; 108(1):141-8. PubMed ID: 17988723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
